Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.

Armuzzi A, Pugliese D, Danese S, Rizzo G, Felice C, Marzo M, Andrisani G, Fiorino G, Nardone OM, De Vitis I, Papa A, Rapaccini GL, Guidi L.

Inflamm Bowel Dis. 2014 Aug;20(8):1368-74. doi: 10.1097/MIB.0000000000000115.

PMID:
24983979
[PubMed - in process]
2.

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission.

Armuzzi A, Pugliese D, Danese S, Rizzo G, Felice C, Marzo M, Andrisani G, Fiorino G, Sociale O, Papa A, De Vitis I, Rapaccini GL, Guidi L.

Inflamm Bowel Dis. 2013 Apr;19(5):1065-72. doi: 10.1097/MIB.0b013e3182802909.

PMID:
23448790
[PubMed - indexed for MEDLINE]
3.

Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.

Halpin SJ, Hamlin PJ, Greer DP, Warren L, Ford AC.

World J Gastroenterol. 2013 Feb 21;19(7):1091-7. doi: 10.3748/wjg.v19.i7.1091.

PMID:
23467174
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Long-term outcome after infliximab for refractory ulcerative colitis.

Ferrante M, Vermeire S, Fidder H, Schnitzler F, Noman M, Van Assche G, De Hertogh G, Hoffman I, D'Hoore A, Van Steen K, Geboes K, Penninckx F, Rutgeerts P.

J Crohns Colitis. 2008 Sep;2(3):219-25. doi: 10.1016/j.crohns.2008.03.004. Epub 2008 May 16.

PMID:
21172214
[PubMed]
5.

Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.

Teisner AS, Ainsworth MA, Brynskov J.

Scand J Gastroenterol. 2010 Dec;45(12):1457-63. doi: 10.3109/00365521.2010.510572. Epub 2010 Aug 11.

PMID:
20701434
[PubMed - indexed for MEDLINE]
6.

Clinical efficacy of infliximab in moderate to severe ulcerative colitis in a latin american referral population.

Juliao F, Marquez J, Aristizabal N, Yepes C, Zuleta J, Gisbert JP.

Digestion. 2013;88(4):222-8. doi: 10.1159/000355529. Epub 2013 Nov 22.

PMID:
24281150
[PubMed - indexed for MEDLINE]
7.

Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.

Sjöberg M, Magnuson A, Björk J, Benoni C, Almer S, Friis-Liby I, Hertervig E, Olsson M, Karlén P, Eriksson A, Midhagen G, Carlson M, Lapidus A, Halfvarson J, Tysk C; Swedish Organization for the Study of Inflammatory Bowel Disease (SOIBD).

Aliment Pharmacol Ther. 2013 Aug;38(4):377-87. doi: 10.1111/apt.12387. Epub 2013 Jun 25.

PMID:
23799948
[PubMed - indexed for MEDLINE]
8.

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis.

Arias MT, Vande Casteele N, Vermeire S, de Buck van Overstraeten A, Billiet T, Baert F, Wolthuis A, Van Assche G, Noman M, Hoffman I, D'Hoore A, Gils A, Rutgeerts P, Ferrante M.

Clin Gastroenterol Hepatol. 2014 Aug 10. pii: S1542-3565(14)01140-9. doi: 10.1016/j.cgh.2014.07.055. [Epub ahead of print]

PMID:
25117777
[PubMed - as supplied by publisher]
9.

Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience.

Yamada S, Yoshino T, Matsuura M, Minami N, Toyonaga T, Honzawa Y, Tsuji Y, Nakase H.

BMC Gastroenterol. 2014 Apr 23;14:80. doi: 10.1186/1471-230X-14-80.

PMID:
24758588
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

Cassinotti A, Actis GC, Duca P, Massari A, Colombo E, Gai E, Annese V, D'Albasio G, Manes G, Travis S, Porro GB, Ardizzone S.

Am J Gastroenterol. 2009 Nov;104(11):2760-7. doi: 10.1038/ajg.2009.410. Epub 2009 Jul 21.

PMID:
19623172
[PubMed - indexed for MEDLINE]
11.

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.

Laharie D, Filippi J, Roblin X, Nancey S, Chevaux JB, Hébuterne X, Flourié B, Capdepont M, Peyrin-Biroulet L.

Aliment Pharmacol Ther. 2013 May;37(10):998-1004. doi: 10.1111/apt.12289. Epub 2013 Mar 21.

PMID:
23521659
[PubMed - indexed for MEDLINE]
12.

Predictors of early response to infliximab in patients with ulcerative colitis.

Ferrante M, Vermeire S, Katsanos KH, Noman M, Van Assche G, Schnitzler F, Arijs I, De Hertogh G, Hoffman I, Geboes JK, Rutgeerts P.

Inflamm Bowel Dis. 2007 Feb;13(2):123-8.

PMID:
17206703
[PubMed - indexed for MEDLINE]
13.

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.

Sjöberg M, Walch A, Meshkat M, Gustavsson A, Järnerot G, Vogelsang H, Hertervig E, Novacek G, Friis-Liby I, Blomquist L, Angelberger S, Karlen P, Grännö C, Vilien M, Ström M, Verbaan H, Hellström PM, Dejaco C, Magnuson A, Halfvarson J, Reinisch W, Tysk C.

Inflamm Bowel Dis. 2012 Feb;18(2):212-8. doi: 10.1002/ibd.21680. Epub 2011 Mar 15.

PMID:
21438096
[PubMed - indexed for MEDLINE]
14.

Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitis.

Barreiro-de Acosta M, Lorenzo A, Mera J, Dominguez-Muñoz JE.

J Crohns Colitis. 2009 Dec;3(4):271-6. doi: 10.1016/j.crohns.2009.06.003.

PMID:
21172286
[PubMed]
15.

Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.

Turner D, Griffiths AM, Veerman G, Johanns J, Damaraju L, Blank M, Hyams J.

Clin Gastroenterol Hepatol. 2013 Nov;11(11):1460-5. doi: 10.1016/j.cgh.2013.04.049. Epub 2013 May 11.

PMID:
23672831
[PubMed - indexed for MEDLINE]
16.

Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.

Subramaniam K, Richardson A, Dodd J, Platten J, Shadbolt B, Pavli P.

Intern Med J. 2014 May;44(5):464-70. doi: 10.1111/imj.12397.

PMID:
24612209
[PubMed - in process]
17.

Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis.

Mañosa M, López San Román A, Garcia-Planella E, Bastida G, Hinojosa J, Gonzalez-Lama Y, Masnou H, Domènech E.

Digestion. 2009;80(1):30-5. doi: 10.1159/000212075. Epub 2009 May 14.

PMID:
19439969
[PubMed - indexed for MEDLINE]
18.

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis.

Rostholder E, Ahmed A, Cheifetz AS, Moss AC.

Aliment Pharmacol Ther. 2012 Mar;35(5):562-7. doi: 10.1111/j.1365-2036.2011.04986.x. Epub 2012 Jan 13.

PMID:
22239070
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Colectomy rate in acute severe ulcerative colitis in the infliximab era.

Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R.

Dig Liver Dis. 2008 Oct;40(10):821-6. doi: 10.1016/j.dld.2008.03.014. Epub 2008 May 9.

PMID:
18472316
[PubMed - indexed for MEDLINE]
20.

Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.

Jürgens M, Laubender RP, Hartl F, Weidinger M, Seiderer J, Wagner J, Wetzke M, Beigel F, Pfennig S, Stallhofer J, Schnitzler F, Tillack C, Lohse P, Göke B, Glas J, Ochsenkühn T, Brand S.

Am J Gastroenterol. 2010 Aug;105(8):1811-9. doi: 10.1038/ajg.2010.95. Epub 2010 Mar 2.

PMID:
20197757
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk